Axcynsis Therapeutics Pte.
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $15M
Investors
- 1
About Axcynsis Therapeutics Pte.
In 2022, the company was founded by Dr. Zou Bin, who also serves as the CEO of the company, under the name Tetris Therapeutics. Two months later, the company changed its name into Axcynsis Therapeutics, and officially opened its office in Singapore in September. In 2023, the company opened its office in Shanghai, China. The company operates as a platform focusing on developing antibody-X conjugate (AXC) therapies to treat cancer. The core technologies the company utilizes are Antibody Discovery Technology, LP (Linker + Payload) Technology, and Conjugation Technology. As of 2023, the company has four pipelines under development, three (AT – 01, AT - 03, AT - 04) in the optimization stage, and one in discovery stage (AT - 00).
Who invested in Axcynsis Therapeutics Pte.
1 investor across 1 round
See all investors in Axcynsis Therapeutics Pte.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 3, 2023
Amount
$15M
Investors
Questions about Axcynsis Therapeutics Pte.
Who invested in Axcynsis Therapeutics Pte.?
Axcynsis Therapeutics Pte. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Axcynsis Therapeutics Pte. raised?
Axcynsis Therapeutics Pte. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Axcynsis Therapeutics Pte. last raise money?
Axcynsis Therapeutics Pte.'s most recent round on record is a Series A, in Jun 2023.
What does Axcynsis Therapeutics Pte. do?
In 2022, the company was founded by Dr.
Where is Axcynsis Therapeutics Pte. headquartered?
Axcynsis Therapeutics Pte. is headquartered in Singapore, Singapore.
Which VCs invest in companies like Axcynsis Therapeutics Pte.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Axcynsis Therapeutics Pte.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Axcynsis Therapeutics Pte.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.